drugset / Trial / NCT04685941

Treatment of Slow-flow After Primary Percutaneous Coronary Intervention With Flow-mediated Hyperemia

NCT04685941

RandomizedParallel-groupOpen-labelTreatment

Summary

A total of 100 patients with ST-elevation myocardial infarction (STEMI) presenting slow-flow after primary-percutaneous coronary intervention (PPCI) will be randomized to pharmacologic treatment with hyperemic drugs versus flow-mediated hyperemia.

Timeline

Start
2021-01-25
Primary completion
2022-10-31
Completion
2022-10-31

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Adenosine Small molecule 500 ug Other
Subject nitroprussiate Unknown 200 ug Other